12:00 AM
Oct 29, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Bronchitol mannitol regulatory update

The U.K.'s NICE issued new draft guidance recommending Bronchitol mannitol from Pharmaxis as an add-on therapy to best standard of care in cystic fibrosis patients, but in a narrower CF population than the one the committee rebuffed earlier this year. The committee now recommends Bronchitol in CF patients for whom treatment with recombinant human...

Read the full 248 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >